Stock MOR MORPHOSYS AG
Add to a list
To use this feature you must be a member
Log inSign up

News MorphoSys AG Deutsche Boerse AG

Equities

MOR

DE0006632003

Real-time Estimate Tradegate
Other stock markets
 11:06:18 2024-07-17 am EDT 		5-day change 1st Jan Change
67.78 EUR +0.04% Intraday chart for MorphoSys AG -0.07% +94.13%
12:42pm Oxford Biomedica Names New Finance Chief MT
11:52am K3 Business sees interim revenue decline AN

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oxford Biomedica Names New Finance Chief
MT
K3 Business sees interim revenue decline
AN
MorphoSys AG - Ad hoc, Merger Squeeze-out Cash Compensation Determined at EUR 68.00
AQ
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
AQ
MorphoSys Informs Nasdaq Stock Market of Delisting Plans After Novartis Merger
MT
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
BU
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
EQ
Novartis Seeks Squeeze Out Approval at MorphoSys AGM
MT
Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
EQ
AFR: MorphoSys AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
MorphoSys AG: Correction of a release from 18/04/2024 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
INDEX-MONITOR: Tui, Rational and Traton in the MDax - Douglas moves up to the SDax
DP
MorphoSys AG(XTRA:MOR) dropped from Germany MDAX Index (Performance)
CI
MorphoSys AG(XTRA:MOR) dropped from Germany TECDAX (Total Return) Index
CI
MorphoSys AG(XTRA:MOR) dropped from Germany TECDAX Index (Price Return)
CI
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
InnoCare Announces the Acceptance of Biologics License Application for Tafasitamab in Combination with Lenalidomide for the treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Adult Patients
AQ
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15
DP
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOR Stock
  4. MOR Stock
  5. News MorphoSys AG